Performance of Vibration-Controlled Transient Elastography and Clinical Prediction Models In Liver Transplant Recipients

Hepatic fibrosis is a strong predictor of clinical outcomes following liver transplantation (LT).1 Despite the centrality of hepatic fibrosis in clinical outcomes, the published literature with noninvasive fibrosis assessment in LT recipients is limited and liver biopsy, despite its invasive nature,...

Full description

Saved in:
Bibliographic Details
Published in:Clinical gastroenterology and hepatology Vol. 21; no. 4; pp. 1100 - 1102.e2
Main Authors: Siddiqui, Mohammad Shadab, Bui, Anh T., Syed, Taseen, Tseng, Michael, Hassouneh, Ramzi, Bhati, Chandra S., Ng, Cheng Han, Arshad, Tamoore, Miller, Austin, Flynn, Sean, Patel, Vaishali, Asgharpour, Amon, Patel, Sohum, Idowu, Michael O., Muthiah, Mark
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-04-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatic fibrosis is a strong predictor of clinical outcomes following liver transplantation (LT).1 Despite the centrality of hepatic fibrosis in clinical outcomes, the published literature with noninvasive fibrosis assessment in LT recipients is limited and liver biopsy, despite its invasive nature, remains the reference standard. Vibration-controlled transient elastography (VCTE) and clinical prediction models (CPM) are point-of-care tests that can provide noninvasive assessment of hepatic fibrosis2–4; however, the data comparing the diagnostic performance of VCTE and CPM in LT recipients are lacking. The current study evaluated the diagnostic performance of VCTE and CPM in LT recipients using best practices in regulatory sciences for biomarker development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
See Acknowledgement for full list of Liver Transplant Biomarker Group
ISSN:1542-3565
1542-7714
DOI:10.1016/j.cgh.2022.02.023